Results 281 to 290 of about 106,022 (294)

Glucagon-like peptide-1 receptor agonists and acute pancreatitis

Diabetes & Metabolism
Kuan-Fu, Liao, Shih-Wei, Lai
openaire   +2 more sources

Glucagon-Like Peptide-1 Receptor Agonists and Cancer—Reply

JAMA Oncology
Hao, Dai, Jingchuan, Guo, Jiang, Bian
openaire   +2 more sources

Glucagon-Like Peptide 1 Receptor Agonist

openaire   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Venous Thromboembolism: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

Journal of the American Heart Association
Huabing Zhang, Yuxiu Li, Fan Ping
exaly  

Glucagon-like peptide-1 receptor agonists: new strategies and therapeutic targets to treat atherosclerotic cardiovascular disease

Frontiers in Pharmacology
Xinyi Cheng, Hu Pengfei, Cheng Xinyi
exaly  

Quantitative Comparison of Glucagon-Like Peptide-1 Receptor Agonists on Weight Loss in Adults: A Systematic Review and Model-Based Meta-Analysis

Diabetes Technology and Therapeutics
Libo Zhao, Xianhua Zhang
exaly  

Glucagon-like peptide-1 receptor agonists and aspiration risk

BMJ
Daniel I, McIsaac, Gregory L, Bryson
openaire   +2 more sources

Glucagon-Like Peptide 1 Receptor Agonists and Risk of Thyroid Cancer: An International Multisite Cohort Study

Thyroid
exaly  

Glucagon-like peptide 1 receptor agonists and uses thereof

2019
WEI YANG, OKAMOTO HARUKA, GROMADA JESPER, DAVIS SAMUEL, MURPHY ANDREW   +4 more
openaire   +6 more sources

Effects of Glucagon-Like Peptide 1 Receptor Agonists on Atrial Fibrillation Recurrence After Catheter Ablation: A Systematic Review and Meta-analysis

Advances in Therapy
Panagiotis Theofilis, Mohamed El-Tanani, Dimitrios Patoulias   +2 more
exaly